Acute cholestatic hepatitis after exposure to isoflurane

Annals of Pharmacotherapy

Volumn 36, Issue 2, 2002, Pages 261-263

  Malnick, Stephen D H ^a   Mahlab, Keren ^a   Borchardt, Jakob ^a   Sokolowski, Nadia ^a   Attali, Malka ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

Author keywords

Cholestatic hepatitis; Isoflurane

Indexed keywords

ALANINE AMINOTRANSFERASE; BILIRUBIN; DIPYRONE; ISOFLURANE;

AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANALGESIA; ARTICLE; BILIRUBIN BLOOD LEVEL; CASE REPORT; CHOLESTATIC HEPATITIS; FEMALE; GENERAL ANESTHESIA; HUMAN; PRIORITY JOURNAL; ROTATOR CUFF;

ACETYLCYSTEINE; ACUTE DISEASE; AGED; ANESTHETICS, INHALATION; BIOPSY; CHOLESTASIS; FEMALE; HEPATITIS, TOXIC; HUMANS; ISOFLURANE; LIVER; LIVER FUNCTION TESTS; URSODEOXYCHOLIC ACID;

EID: 0036164279     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1A009     Document Type: Article

References (22)

1. Fulminant hepatic failure after repeated exposure to isoflurane anesthesia: A case report
2. A report of hepatic necrosis and death following isoflurane anesthesia
3. Gallstones and isoflurane hepatitis
4. Isoflurane hepatotoxicity: A case report and review of the literature
5. Suspected isoflurane hepatitis in an obese patient with a history of halothane hepatitis
6. Halothane hepatitis in a renal transplant patient previously exposed to isoflurane
7. Massive hepatic necrosis and death following repeated isoflurane exposure: Case report and review of the literature
8. Fatal hepatic necrosis after isoflurane anaesthesia
9. Postoperative elevation of serum transaminases following isoflurane anesthesia
10. Hepatic dysfunction after isoflurane anesthesia
11. Hepatic dysfunction after repeated isoflurane administration
12. Risks of agranulocytosis and aplastic anemia: A first report of their relation to drug use with special reference to analgesics. The International Agranulocytosis and Aplastic Anemia Study
13. Improvement by acetylcysteine of hemodynamics and oxygen transport in fulminant hepatic failure
14. Ursodeoxycholic acid in chronic liver disease
15. Postoperative jaundice
16. Hepatic necrosis associated with halothane anesthesia
17. Hepatotoxicity and inhalational anesthetics: Views in the era of isoflurane
18. Isoflurane hepatotoxicity in a patient with a previous history of halothane-induced hepatitis
19. Enflurane metabolism produces covalently bound liver adducts recognized by antibodies from patients with halothane hepatitis
20. Potential metabolic basis for enflurane hepatitis and the apparent cross-sensitization between enflurane and halothane
21. A method for estimating the probability of adverse drug reactions